Karin Jorga

A Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics

Hannah M. Jones, Neil Parrott, Karin Jorga et al. · Clinical Pharmacokinetics · 2006 · 348 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Model-Based Prediction of Phase III Overall Survival in Colorectal Cancer on the Basis of Phase II Tumor Dynamics

Laurent Claret, Pascal Girard, Paulo M. Hoff et al. · Journal of Clinical Oncology · 2009 · 271 citations · Full text

Medicine, Oncology, Pharmacology +17

A Guide to Rational Dosing of Monoclonal Antibodies

Shuang Bai, Karin Jorga, Denise Jin et al. · Clinical Pharmacokinetics · 2012 · 163 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Pharmacokinetics of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors: the Role of Alpha-1-Acid Glycoprotein Binding

Richard Graham, Bert L. Lum, Sravanthi Cheeti et al. · Clinical Cancer Research · 2011 · 117 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +13

Pharmacokinetic‐pharmacodynamic interaction between the COMT inhibitor tolcapone and single‐dose levodopa.

Jasper Dingemanse, Karin Jorga, G. Zürcher et al. · British Journal of Clinical Pharmacology · 1995 · 113 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14